|
AXIM Axim Biotechnologies Inc 1514946 |
| Income Statement |
|
Revenue
|
axim_10q
|
17,479 |
|
Net Income
|
axim_10q
|
-2,269,815 |
|
Profit Margin
|
|
-12985.95% |
| Balance Sheet |
|
Current Assets
|
20,243 |
|
Assets
|
3,727,695 |
|
Current Liabilities
|
6,572,371 |
|
Liabilities
|
13,262,485 |
|
Equity
|
-9,534,790 |
|
Shares Out
|
301,959,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-514,048 |
|
Investing Cash Flow
|
-2,839 |
| Market Analysis |
Market Cap
|
1,005,524 |
|
BVPS
|
0.39 |
|
PB
|
0.20 |
|
EPS
|
-0.02 |
|
PS
|
14.38 |
|
FCF
|
-516,887 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AXIM documents filed with the SEC.
AXIM Filings
Clear
